Pre-earnings options volume in Prokidney (PROK) Corp is normal with puts leading calls 9:4. Implied volatility suggests the market is anticipating a move near 15.7%, or 38c, after results are released. Median move over the past eight quarters is 2.2%.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PROK:
- Prokidney Corp options imply 13.0% move in share price post-earnings
- Prokidney’s REACT Study: A Promising Step for Kidney Disease Treatment
- Largest borrow rate increases among liquid names
- ProKidney’s Hold Rating: Balancing FDA Alignment and Extended Approval Timeline
- ProKidney’s Clinical Trials and Regulatory Developments Lead to Hold Rating Amid Uncertainty